JPS63119764A - Emergency adhesive plaster - Google Patents
Emergency adhesive plasterInfo
- Publication number
- JPS63119764A JPS63119764A JP25559087A JP25559087A JPS63119764A JP S63119764 A JPS63119764 A JP S63119764A JP 25559087 A JP25559087 A JP 25559087A JP 25559087 A JP25559087 A JP 25559087A JP S63119764 A JPS63119764 A JP S63119764A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- release sheet
- pad
- sheet
- blister
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000853 adhesive Substances 0.000 title claims description 13
- 230000001070 adhesive effect Effects 0.000 title claims description 13
- 239000011505 plaster Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims description 44
- 229940079593 drug Drugs 0.000 claims description 41
- 239000011248 coating agent Substances 0.000 claims description 16
- 238000000576 coating method Methods 0.000 claims description 16
- 206010052428 Wound Diseases 0.000 description 17
- 208000027418 Wounds and injury Diseases 0.000 description 17
- 239000012528 membrane Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- -1 sulfinmidine Chemical compound 0.000 description 2
- SIACJRVYIPXFKS-UHFFFAOYSA-N (4-sulfamoylphenyl)methylazanium;chloride Chemical compound Cl.NCC1=CC=C(S(N)(=O)=O)C=C1 SIACJRVYIPXFKS-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- OJFZXRZZXBFEAP-UHFFFAOYSA-N 5-chloro-1,6-dimethylcyclohexa-2,4-dien-1-ol Chemical compound ClC=1C(C(C=CC1)(C)O)C OJFZXRZZXBFEAP-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- DJDFFEBSKJCGHC-UHFFFAOYSA-N Naphazoline Chemical compound Cl.C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 DJDFFEBSKJCGHC-UHFFFAOYSA-N 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003290 cortisone acetate Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960004760 naphazoline hydrochloride Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Abstract] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
一般に繁用の簡易救急絆創膏は、殺菌消毒剤、創傷治療
剤を含浸させたガーゼを通気孔を有する粘着性のシート
に装埴し、使用時に裏面の剥離紙をはがして前記ガーゼ
部を傷口局所に当てて使用するようにしたものである。[Detailed Description of the Invention] A commonly used simple emergency bandage consists of gauze impregnated with a sterilizing disinfectant or wound treatment agent, wrapped in an adhesive sheet with ventilation holes, and the release paper on the back is peeled off before use. The gauze portion is used by applying the gauze portion to the wound.
しかしながら、これらの従来品においては、予めガーゼ
に薬液を含浸させておくため、経時的に薬液が蒸散し、
また効力の失活をきたすばかシでなく、局所への当接に
際してはガーゼ部が乾燥状態となっているため、傷口を
いためるおそれがあり、使用に際しても、痛みを感じさ
せる等の欠点があった。However, in these conventional products, because the gauze is impregnated with the drug solution in advance, the drug solution evaporates over time.
In addition, the gauze part is dry when applied to the local area, so there is a risk of damaging the wound, and there are disadvantages such as causing pain when using it. Ta.
また、薬剤被覆膜により薬剤をシールしたブリスター部
を有する救急絆創膏であって、使用に際してブリスター
部を指で押圧して薬剤被覆膜を破壊することにより薬剤
をパッドに含浸させるものも知られている（実公昭５４
−２３１９７号公報、米国特許第３．２９７．０３２号
明細書）。There are also known emergency bandages that have a blister part with a drug sealed in it by a drug-coated film, and when used, the pad is impregnated with the drug by pressing the blister part with your finger to break the drug-covering film. (Jikko 54)
-23197, U.S. Patent No. 3.297.032).
しかしながら、この型の救急絆創膏は、ブリスター部が
平滑な表面を有するものであるため、これを押圧した時
、力がブリスター部全体に分散し、抑圧部全体が不規則
に窪んでしまうため、ブリスター部が薬剤被覆膜に到達
してこれを破壊することは非常に困難であった。However, since the blister part of this type of emergency bandage has a smooth surface, when the blister part is pressed, the force is dispersed throughout the blister part, causing the entire suppression part to become irregularly depressed. It was very difficult for the drug to reach and destroy the drug-coated membrane.
また、例えブリスター部の内部圧力の上昇によって薬剤
被覆膜が破壊された場合でも、破壊箇所はブリスター部
と薬剤被覆膜の接線部分となり、薬剤がパッド外縁部又
はパッド外に移動し、その効果が損なわれるという問題
があった。In addition, even if the drug coating film is destroyed due to an increase in the internal pressure of the blister part, the breakage point will be a tangent between the blister part and the drug coating film, and the drug will move to the outer edge of the pad or outside the pad, and There was a problem that the effect was lost.
また、米国特許第４，１１７，８４１号明細書には接着
剤が塗布された絆創膏ストリップの中央部下表面に、薬
剤を保持する空間を形成して液体不浸透性のシート（或
いは液体不浸透性層を介して液体浸透性のシート）を設
け、該空間内の絆創膏ストリップの下表面にプラスチッ
クの歯のような突起体を設け、また該空間内に薬剤を充
填した絆創膏について記載されている。Further, US Pat. No. 4,117,841 discloses that a space for holding a drug is formed on the central lower surface of an adhesive-coated bandage strip, and a liquid-impermeable sheet (or A bandage is described in which a liquid-permeable sheet is provided between the layers, a plastic tooth-like protrusion is provided on the lower surface of the bandage strip in the space, and a drug is filled in the space.
この絆創′膏は、使用に際し、前記７−トを突起体に指
により押しつけ、シートを破壊して、薬剤を傷口に直接
垂らした後、絆創膏を傷口に適用するものであるが、指
によりシートを突起体に押しつけシートを破壊する操作
は、突起体の先鋭部分によシ指を痛め、または傷つける
恐れがあり、またシートの破壊時に一部の薬液が指に付
着し、更にその後薬液を傷口に垂らす際に一部の薬液が
傷口から滴り落ちて薬液が無駄になる。また、この絆創
膏の基体的欠点として。When using this bandage, the above-mentioned 7-t is pressed against the protrusion with a finger, the sheet is broken, and the medicine is dripped directly onto the wound, and then the bandage is applied to the wound. The operation of pressing the sheet against the protrusion to destroy the sheet may injure or injure the fingers due to the sharp part of the protrusion, and some of the chemical solution may adhere to the fingers when the sheet is destroyed, and furthermore, the chemical solution may be applied afterwards. When applying the medicine to the wound, some of the medicine drips from the wound and is wasted. Also, as a basic drawback of this bandage.
絆創−１Ｆは突起体が残存したまま、かつ、その先鋭部
分が傷口に向った状態で傷口に適用されるので、突起体
によシ傷をいっそう傷める危険性があり、そうでなくて
も使用感が極めて悪いという欠点を有するものである。Bond wound-1F is applied to the wound with the protrusion remaining and the sharp end facing the wound, so there is a risk that the protrusion will further damage the wound. It has the disadvantage of being extremely uncomfortable to use.
本発明は上記した従来技術の欠点を解決したものである
。The present invention solves the above-mentioned drawbacks of the prior art.
即ち、本発明の救急絆創膏は、パッドを装着した粘着シ
ートと剥離シートとからなシ、該剥離シートには、薬剤
被覆膜によりその下面がシールされ、かつ薬剤を内包す
るブリスター部が前記パッド上に位置して設けられてお
９、剥離シートのブリスター部の両サイドには、剥離シ
ートの巾方向に向けてミシン目が設けられていることを
特徴とする。That is, the emergency bandage of the present invention consists of an adhesive sheet on which a pad is attached and a release sheet, the release sheet has a lower surface sealed with a drug coating film, and a blister portion containing a drug is attached to the pad. Perforations are provided on both sides of the blister portion of the release sheet in the width direction of the release sheet.
本発明の救急絆創膏は、剥離７−トのブリスター部の両
サイドに剥離シートの巾方向に向けてミシン目が設けら
れてい′るため、使用に際して該ミシン目に沿って剥離
シートを折シ曲げることにより、若しくは、ブリスター
部を指で押圧することによシ、薬剤被覆膜は、無理なく
破壊され、薬剤はパッドに無駄なく確実に移動する。The emergency bandage of the present invention has perforations in the width direction of the release sheet on both sides of the blister part of the release sheet, so the release sheet must be folded along the perforations when used. By this, or by pressing the blister part with a finger, the drug coating film is easily destroyed and the drug is transferred to the pad without wasting it.
このようにして、薬剤をパッドに移動させた後、薬剤被
覆膜およびブリスター部を有する剥離シートは粘着シー
トから除去される。そして傷口には薬剤の付いたパッド
を有する粘着シートのみが適用されるので使用上の危険
性や違和感がない。After the drug is transferred to the pad in this manner, the release sheet having the drug coating film and the blister portion is removed from the adhesive sheet. Since only the adhesive sheet with the drug-applied pad is applied to the wound, there is no danger or discomfort during use.
本発明に使用する薬剤については、殺菌消毒剤としてグ
ルコン酸クロルヘキシジン、塩化ベンザルコニウム、ク
ロルキシレノール、アクリノール、チアノトール、塩化
テカリニウム、スルフィンミジン、スルファミン、ニト
ロフラゾン。The agents used in the present invention include chlorhexidine gluconate, benzalkonium chloride, chlorxylenol, acrinol, thianotol, tequalinium chloride, sulfinmidine, sulfamine, and nitrofurazone as disinfectants.
ホウ酸、ホモスルファミン、トリクロカルパン等があり
、創傷部収斂治癒促進剤として酸化亜鉛、塩酸ピリドキ
シン、酢酸トコフェロール。These include boric acid, homosulfamine, triclocarpan, etc., and zinc oxide, pyridoxine hydrochloride, and tocopherol acetate as wound astringent healing promoters.
シバルミチン酸ピリドキ７ノ等、止血剤としては塩酸ナ
ファゾリン、硫酸亜塩、塩酸エフェドリン等、抗炎症剤
としてはプレドニノ°ロン、デキサメサゾン、酢酸コル
チゾン等のステロイド剤、グリチルレチン、塩化リゾチ
ーム等、抗ヒスタミン剤としてマレイン酸クロルフェニ
ラミン、塩酸ジフェンヒドラミン等がある。Hemostatic agents include naphazoline hydrochloride, subsulfates, ephedrine hydrochloride, etc. Anti-inflammatory agents include steroids such as prednisolone, dexamethasone, cortisone acetate, glycyrrhetin, lysozyme chloride, etc. Antihistamines include maleic acid Examples include chlorpheniramine and diphenhydramine hydrochloride.
又、局麻剤としてはリドカイン、アミノ安息香酸エチル
、塩酸プロカイン、塩酸ジブカイン、塩酸テトラカイン
、塩酸パラブチルアミノ安息香酸ジエチルアミノエチル
等がある。Local narcotics include lidocaine, ethyl aminobenzoate, procaine hydrochloride, dibucaine hydrochloride, tetracaine hydrochloride, diethylaminoethyl parabutylaminobenzoate hydrochloride, and the like.
これらの薬剤は目的に合わせ、単味で又は複数の配合剤
とすることができ、又、薬剤の性状は溶液状の他、軟膏
状、グリース状、粉末等流動性のあるものであれば以下
なる性状でもよい。Depending on the purpose, these drugs can be used singly or in combination, and the properties of the drugs are as follows, as long as they are fluid, such as solution, ointment, grease, and powder. It may have the following properties.
粘着シートは、通常用いられるものでもよく、パッドは
、脱脂綿その他各種の綿、不織布等を使用することがで
き、適宜その中央部をへこませた形状とすることができ
る。又、通常の方法により裏面を防水処理してもよい。The pressure-sensitive adhesive sheet may be a commonly used adhesive sheet, and the pad may be made of absorbent cotton, various types of cotton, nonwoven fabric, or the like, and may be appropriately shaped with a concave central portion. Further, the back surface may be waterproofed by a conventional method.
剥離シートは、塩化ビニール樹脂その他の合成樹脂等の
材質により成型され、中央部に円形。The release sheet is molded from a material such as vinyl chloride resin or other synthetic resin, and has a circular shape in the center.
だ円形若しくは矩形状のブリスター部を設け、又剥離シ
ートをめくり易くするために端部にスリットを設けるの
がよい。It is preferable to provide an oval or rectangular blister portion, and to provide a slit at the end to make it easier to turn over the release sheet.
剥離シートのブリスター部下面には、薬剤を使用時まで
パッドに接触させるのを、防止するための薬剤被覆膜が
シールしである。薬剤被覆膜はアルミ箔、グラシン紙等
の破壊されやすい膜が採用される。該被覆膜は、薬剤を
保護しうる大きさでよいが、剥離シートの下面全体に設
けられていてもさしつかえない。A drug coating film is sealed on the lower surface of the blister of the release sheet to prevent the drug from coming into contact with the pad until use. As the drug coating membrane, a membrane that is easily destroyed, such as aluminum foil or glassine paper, is used. The coating film may be large enough to protect the drug, but may be provided on the entire lower surface of the release sheet.
以下、図面により本発明を更に詳細に説明する。第１図
は本発明の救急絆創膏の一実施例の断面図、第２図は第
１図のＡ−Ａ’縦断面図、第３図は剥離シートの平面図
である。Hereinafter, the present invention will be explained in more detail with reference to the drawings. FIG. 1 is a sectional view of an embodiment of the emergency bandage of the present invention, FIG. 2 is a longitudinal sectional view taken along line AA' in FIG. 1, and FIG. 3 is a plan view of a release sheet.
図面に於て、１はパッド２′？：装着した粘着シートで
あり、パッド上部には薬剤３が、薬剤被覆膜５と剥離シ
ート４に設けられたブリスター部６との間の空間内に内
包されている。そして、剥離シートのブリスター部の両
サイドには、剥離シートの巾方向に向けてミシン目８が
設けられている。また剥離シート４の端部にはスリット
７が刻設しである。救急絆創膏を使用するに際しては、
ミシン目８に沿って剥離シートを折り曲げるか、或いは
ブリスター部を指で押圧して薬剤被覆膜５を破壊するこ
とによシ薬剤３をパッド２上に移動させる。In the drawing, 1 is pad 2'? : This is an attached adhesive sheet, and the drug 3 is contained in the space between the drug coating film 5 and the blister part 6 provided on the release sheet 4 in the upper part of the pad. Perforations 8 are provided on both sides of the blister portion of the release sheet in the width direction of the release sheet. Furthermore, a slit 7 is cut into the end of the release sheet 4. When using emergency bandages,
The drug 3 is moved onto the pad 2 by folding the release sheet along the perforations 8 or by pressing the blister portion with a finger to break the drug coating film 5.
次いで、スリット７ｔ−折り曲げ剥離シート４を粘着シ
ートよシはがし、新鮮な薬剤の付いたパッド２の部分を
創傷面に当接使用する。Next, the slit 7t and the peeling sheet 4 are peeled off from the adhesive sheet, and the part of the pad 2 with the fresh drug applied is brought into contact with the wound surface.
また、本発明の救急絆創膏に於ては、第４図に示すよう
に、ブリスター部６に凹状の突起９を設けることができ
る。このようにブリスター部に凹状の突起を設けておく
と、該凹状の突起の窪み部分に指をかけて押圧すること
ができるのでブリスター部の押圧操作がしやすく、そし
て突起部分は形状的にその周辺部分より硬いため、これ
を上方よシ抑圧すれば突起部分は、その形状が壊れるこ
となく、薬剤被覆膜に到達し、その所望の場所、一般的
にはパッドの中央部に対応する箇所の薬剤被覆膜を破壊
するので薬剤のパッドへの移動をよシ確実に行うことが
できる。Furthermore, in the emergency bandage of the present invention, a concave projection 9 can be provided on the blister portion 6, as shown in FIG. By providing a concave protrusion in the blister part in this way, it is possible to press the blister part by placing a finger on the recessed part of the concave protrusion, making it easier to press the blister part. Since it is harder than the surrounding area, if you press it upward, the protruding area will reach the drug coating film without breaking its shape, and will reach the desired location, which generally corresponds to the center of the pad. Since the drug coating film is destroyed, the transfer of the drug to the pad can be carried out more reliably.
本発明の効果は次のとおりである。The effects of the present invention are as follows.
本発明の救急絆創膏は、剥離シートのブリスター部の両
サイドに剥離シートの巾方向に向けてミシン目が設けら
れているため、使用に際して該ミシン目に沿って剥離シ
ートを折シ曲げることによ９％若しくはブリスター部を
指で押圧することにより薬剤被覆膜は容易に、かつ確実
に破壊される。そして、薬剤はパッドに無駄なく、確実
に移動する。また、薬剤をパッドに移動させた後、薬剤
被覆膜およびブリスター部を有する剥離シートは粘着シ
ートから除去され、傷口には新鮮な薬剤が付いたパ・ン
ドを有する粘着シートのみが適用され、米国特許第４１
１，８４１号明細書の絆創膏のように突起体のような不
要物が傷口部分に当接されることがないので傷口に対し
て違和感がなく、かつ安全に使用することができ、殺菌
、消毒、治療の所望の目的を有効に達成できるものであ
る。Since the emergency bandage of the present invention has perforations in the width direction of the release sheet on both sides of the blister part of the release sheet, the release sheet can be folded along the perforations during use. By pressing the 9% or blister portion with a finger, the drug coating film is easily and reliably destroyed. Then, the drug is transferred to the pad reliably without any waste. Also, after transferring the drug to the pad, the release sheet with the drug coating film and the blister part is removed from the adhesive sheet, and only the adhesive sheet with the pad with fresh drug is applied to the wound. US Patent No. 41
Unlike the bandage in Patent No. 1,841, unnecessary objects such as protrusions are not brought into contact with the wound, so there is no discomfort to the wound, and it can be used safely, and is sterilized and disinfected. , which can effectively achieve the desired purpose of treatment.
第１図は、本発明の救急絆創膏の平面図、第２図は、第
１図のＡ −Ａ’縦断面図、第５図は、第１図の救急絆
創膏の剥離シートの平面図、第４図は、他の実施例にお
ける剥離シートの縦断面図。
１・・・・・・粘着シート
２・・・・・・パッド
６・・・・・・薬剤
４・・・・・・剥離シート
５・・・・・・薬剤被覆膜
６・・・・・・ブリスター部
７ ・・・・・・ ス リ ッ ト８・・・・・・
ミシン目
？・・・・・・凹状突起
（は刀）２名）
第１図
１・・＠１＞−ト ２・・昌°ッド
３・・・１に膚１７゛ スリット
８“ ミ・〉ン目 ９・・ 凹ｅｑＬ％る第
２図
才３図
才４図FIG. 1 is a plan view of the emergency bandage of the present invention, FIG. 2 is a longitudinal sectional view taken along the line A-A' in FIG. 1, and FIG. FIG. 4 is a longitudinal cross-sectional view of a release sheet in another example. 1... Adhesive sheet 2... Pad 6... Drug 4... Release sheet 5... Drug coating film 6... ...Blister part 7 ...Slit 8 ...
Perforation? ...Concave projection (sword) 2 people) Fig. 1 1...@1>-t 2...Changed
3...1 skin 17゛ slit
8" M〉〉目 9... Concave eqL%ru 2nd figure 3rd figure 4th figure
Claims (1)
、該剥離シートには、薬剤被覆膜によりその下面がシー
ルされ、かつ薬剤を内包するブリスター部が前記パッド
上に位置して設けられており、剥離シートのブリスター
部の両サイドには、剥離シートの巾方向に向けてミシン
目が設けられていることを特徴とする救急絆創膏。It consists of an adhesive sheet on which a pad is attached and a release sheet, the release sheet has a lower surface sealed with a drug coating film, and a blister portion containing the drug is provided on the pad, An emergency bandage characterized in that perforations are provided on both sides of the blister portion of the release sheet in the width direction of the release sheet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25559087A JPS63119764A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25559087A JPS63119764A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP41048790A Division JPH03247335A (en) | 1990-12-13 | 1990-12-13 | Emergency adhesive bandage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63119764A true JPS63119764A (en) | 1988-05-24 |
| JPH0371901B2 JPH0371901B2 (en) | 1991-11-14 |
Family
ID=17280837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25559087A Granted JPS63119764A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63119764A (en) |
-
1987
- 1987-10-09 JP JP25559087A patent/JPS63119764A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0371901B2 (en) | 1991-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880003941Y1 (en) | First aid adhesive tape | |
| US2579403A (en) | Medical bandage | |
| US7745683B2 (en) | Deformable and conformable wound protecting apparatus and its method of application | |
| US4176664A (en) | Impregnated bandage | |
| US7048706B2 (en) | Hypoallergenic bandage | |
| US20170105877A1 (en) | Wound dressing | |
| US20090099496A1 (en) | Pressure bandage with medication delivery system | |
| JPH0556976B2 (en) | ||
| US3366112A (en) | Adhesive bandage having container of liquid medicament | |
| US20160270968A1 (en) | Two-part bandage with replaceable wound covering portion | |
| JPH01107761A (en) | Adhesive-applied dressing and its applicator | |
| US2340142A (en) | Surgical dressing | |
| US3297032A (en) | Adhesive bandage having container of medicament carried by removable protector strip | |
| KR20000063010A (en) | Adhesive bandage for first aid | |
| WO2007048171A1 (en) | A medicated dressing for wound healing | |
| JPH0157580B2 (en) | ||
| JPS63119764A (en) | Emergency adhesive plaster | |
| JP4136182B2 (en) | Emergency bandage | |
| JPH061135Y2 (en) | First aid bandage | |
| JPH07308339A (en) | Aseptic packing for wound | |
| JPS63119763A (en) | Emergency adhesive plaster | |
| JPH04329951A (en) | Bandage for emergency | |
| JPH03247335A (en) | Emergency adhesive bandage | |
| KR880003940Y1 (en) | First aid adhesive tape | |
| JPH0432099Y2 (en) |